Research ArticleFragile X Syndrome

Effects of STX209 (Arbaclofen) on Neurobehavioral Function in Children and Adults with Fragile X Syndrome: A Randomized, Controlled, Phase 2 Trial

Science Translational Medicine  19 Sep 2012:
Vol. 4, Issue 152, pp. 152ra127
DOI: 10.1126/scitranslmed.3004214

Log in to view full text

As a service to the community, AAAS/Science has made this article free with registration.

Navigate This Article